Cargando…
Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy
Background: Matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) are regulating enzymes of the extracellular matrix. A systemic imbalance of MMP-9 and TIMP-1, thought to reflect an imbalance of the extracellular matrix homeostasis, is previously associated with po...
Autores principales: | Sørensen, Jakob Ø., Subhi, Yousif, Molbech, Christopher R., Krogh Nielsen, Marie, Sørensen, Torben L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356191/ https://www.ncbi.nlm.nih.gov/pubmed/32429088 http://dx.doi.org/10.3390/vision4020027 |
Ejemplares similares
-
T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2017) -
Valsalva-Related Subretinal Hemorrhage as a Presenting Symptom of Polypoidal Choroidal Vasculopathy
por: Subhi, Yousif, et al.
Publicado: (2017) -
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
por: Zhalka, Fidaa El, et al.
Publicado: (2022) -
The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification
por: van Dijk, Elon H. C., et al.
Publicado: (2020) -
Polypoidal Choroidal Vasculopathy in Asians
por: Wong, Chee Wai, et al.
Publicado: (2015)